View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Making Global Clinical Trials Easier for Patients & for Sites at the 5th Annual Global Clinical Trials Conference


  • May 28, 2014

  • The Executing Global Clinical Trials conference announced today that the voice of the patient in shaping global clinical trials is central to the 5th annual event. “Making global trials easier for patients and sites is critical to the future of drug development,” says, Kristen Pisanelli, Conference Producer.

    Harvard Global Health Institute, NPS Pharma, and Bayer Healthcare lead discussions on the development of patient-centric global protocols as well as how to work with patient advocacy groups and incorporate investigator and patient feedback into study designs on September 10th, 2014 at the Fairmont Copley Plaza in Boston, MA.

    Vertex Pharmaceuticals is confirmed to lead a talk on driving faster patient access in global trials and Purdue Pharma, along with Trevi Therapeutics, team up to give a session on rethinking best practices to partner with global investigative sites.

    Global clinical trial veteran Christopher Gallen, CEO, SK Biopharmaceuticals, chairs the conference, which kicks off with a featured presentation by Thomas Lonngren, former Head of EMA, and also includes a risk-based monitoring case study by Quintiles.

    “The constant change in technology in our industry makes global clinical trials interesting and challenging, but the core issues remain: finding and retaining patients, and ensuring quality control,” says Thomas Haag, Data Integrity Process Expert at Novartis, and conference advisor.

    The Global Clinical Trials conference offers concrete topics impacting management of clinical studies globally by finding the right balance between recruitment, cost savings, future regulatory obligations, and managing relationships with global service providers. This conference is offered as a one-day event, or can be combined with the Disruptive Innovations to Advance Clinical Trials conference on September 11-12 in the same venue.